Follow actress and producer Gina Torres' motto, "Be ready, stay ready," and read her advice on advocating for heart health: https://amgen.ly/3WXG4lk Motivated by her experience with her parents' high LDL (“bad”) cholesterol, Gina is embarking on a collaboration with Amgen and the American Academy of Family Physicians to drive urgency around the importance of LDL-C testing in the Hispanic community to help them understand their cardiovascular risk. Amplifying stories like Gina’s is just one of the ways in which Amgen is taking a dynamic approach to help ensure diverse audiences have the information and resources to access proper cardiovascular care.
About us
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. See our Community Guidelines: bit.ly/smcgl See our Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
- Website
-
http://www.amgen.com
External link for Amgen
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Thousand Oaks, CA
- Type
- Public Company
- Founded
- 1980
- Specialties
- Biologics, Human therapeutics, and Development of novel products
Locations
Employees at Amgen
Updates
-
Today the first shipments of the first and only approved BiTE® immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) are on their way to wholesalers across the country. 🔗 Learn more about this innovative option: https://amgen.ly/3X35AWL
-
Today and every day, we celebrate the researchers, patients, advocacy partners, and others in the healthcare community who make clinical trials possible. Narimon Honarpour, SVP, global development, shares why it takes all of us to develop medicines for a healthier world. 🔗 Learn about Amgen's work in clinical trials here: https://amgen.ly/4arkOHS #ClinicalTrialsDay #CTD2024
-
Amgen and AstraZeneca announce joint research findings in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Findings will be shared at the American Thoracic Society‘s international conference. 🔗 https://amgen.ly/3K8BRnm #ATS2024
-
Today we published our new ESG report, detailing our comprehensive approach to corporate responsibility. The report outlines our ongoing commitment to improving healthcare, advancing educational opportunities, promoting sustainability, and upholding the highest ethical standards. 🔗 Learn more at: https://bit.ly/3QGKSb5
-
Today, the U.S. FDA approved Amgen’s delta-like ligand 3-targeting Bispecific T-cell Engager (BiTE®) immunotherapy in adults with extensive-stage small cell lung cancer (ES-SCLC). Amgen is proud to deliver the first targeted immunotherapy to this patient population. 🔗 Press release: https://amgen.ly/3X35AWL
-
Of the estimated 10 million Americans with #osteoporosis, a staggering 8 million are women. Today’s Bone Health Panel at the Hearst Health Lab underscores the importance of empowering women to reshape this narrative. With a longstanding legacy in osteoporosis research and treatment, Amgen is committed to supporting women in their journey of managing postmenopausal osteoporosis. Thank you, Dr. Kristi Tough DeSapri, MD, NCMP, CCD, ONEYOGAHOUSE Founder & CEO Anna Haddad, patient advocate Laura, and Hearst Editorial Director jane francisco for coming together to explore how women can take control of their bone health during Osteoporosis Month and beyond. #AmgenSponsored #HearstHealthLab
-
Before supporting the health of others, our benefits empower you to take care of and enhance your own health. Amgen resources give you everything you need—and more—to support yourself and your family. Learn more: https://bit.ly/3Hpvyus
-
We are honored to report that Amgen has been ranked #1 among 15 pharmaceutical peers in overall corporate reputation among U.S. groups familiar with us in PatientView's 2023 'Corporate Reputation of Pharma' survey. Patient communities play a vital role in shaping our work, and we’re excited to be making a positive impact in meeting their needs. 🔗 Learn more about what these patient groups have to say about the pharmaceutical industry as a whole: https://lnkd.in/dhzjjyfG